Sacituzumab govitecan for Named Patient Import

Sacituzumab govitecan for Patients in India

Sacituzumab govitecan, an FDA approved medication is a Trop-2-directed antibody and topoisomerase inhibitor drug conjugate. It has two known indications. Oncologists recommend this medication for metastatic triple-negative breast cancer treatment. It is also indicated for the management of metastatic urothelial cancer. Sacituzumab govitecan is developed and promoted by Gilead Sciences. It is known by its brand name Trodelvy. The commercially available strength is Trodelvy 180 mg per vial.

Sacituzumab or Trodelvy in India is not accessible from the regular oncology centres or pharmacies. It is because the product is not locally registered yet. But, Indian patients have official channels through Named Patient procurement process. The internationally approved commercial vials can be sourced based on the medical advice. Oncologists are known to prescribe specialized medications for various approved indications even though they are not immediately available. Patients can conveniently source or procure those medications by applying for the relevant permits from India.

Sacituzumab govitecan in India? Seek professional guidance

Being an Indian patient searching for Trodelvy price in India, you can rely on us for experience and expertise. We have been assisting patients with procurement of various advanced medications like Sacituzumab govitecan in India. Our approach is completely process driven and will ensure you are at ease throughout. We will put you across the right sources who are reliable and can expedite the import process for the patients. We understand that the timelines matter the most for lifesaving medicines and our team will

You may Email us (nhs@noelbiotech.com) or call us (+ 91 9677010046 / + 91 9929277766).